Delivery Order SPE2DB22D1002-SPE2DB25FKTS5

Award Date 11/1/24
Potential Completion Date 11/4/24
Potential Value $4.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $11,824.53, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Vemlidy 25 mg tablets and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,664.03 Firm Fixed Price Delivery Order contract is for the supply of Vemlidy 25 mg tablets. The contract has an ultimate completion date of May 17, 2023. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of Vemlidy 25 mg tablets. The contract, valued at $10,975.25, is a Delivery Order with a Firm Fixed Price pricing type. The contract has an ultimate completion date of August 27, 2024. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including military treatment facilities and veterans' hospitals. This...
This federal contract award, valued at $8,037.59, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and medical supplies to support...
This federal contract award, valued at $2,686.26, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Vemlidy 25 mg tablets and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,665.54 firm fixed-price delivery order is for the medication Vemlidy 25 mg tablet, with a performance period ending on May 2, 2025. The contract is not designated as a set-aside and represents an open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
This federal contract award from the Defense Logistics Agency (DLA) is a delivery order worth $3,946.95 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Vemlidy 25 mg tablets. The award has an ultimate completion date of May 12, 2025 and is a firm fixed-price contract. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,816.32 Firm Fixed Price Delivery Order is for the supply of VEMLIDY 25 MG TABLET UU 30S, with a period of performance through January 3, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,807.14 fixed-price contract is for the delivery of Vemlidy 25 mg tablets to support federal healthcare programs. The contract has a completion date of March 29, 2023 and was awarded on March 28, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,473.77 firm fixed-price delivery order is for the supply of Vemlidy 25 mg tablets, a medication used in the treatment of Hepatitis B. The contract has an ultimate completion date of May 9, 2025 and does not utilize a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
  • SPE2DB22D1002
    Indefinite Delivery Contract
  • SPE2DB22D1002-SPE2DB25FKTS5
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,243.35 firm fixed-price delivery order is for the medical product Vemlidy 25 mg Tablet, with a period of performance through November 4, 2024.

AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities. These IDCs enable efficient government procurement of critical pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.

The contract award does not have a set-aside designation, indicating open competition. As a major pharmaceutical distributor, AmerisourceBergen plays a significant role in supplying essential medical products to various federal agencies, including the DLA which supports military treatment facilities and veterans' healthcare programs.

Generated 1/31/25, 9:17 AM